Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ali Keshavarzian and James Moy.
Ali Keshavarzian
Connection Strength
0.252
James Moy
  1. Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2. mBio. 2023 02 28; 14(1):e0339322.
    View in: PubMed
    Score: 0.054
  2. Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-?B signaling. JCI Insight. 2022 09 22; 7(18).
    View in: PubMed
    Score: 0.052
  3. Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-?B signaling. JCI Insight. 2022 08 08; 7(15).
    View in: PubMed
    Score: 0.052
  4. Erratum for Adeniji et al., "COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions". mBio. 2021 Jun 29; 12(3):e0124421.
    View in: PubMed
    Score: 0.048
  5. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions. mBio. 2021 04 20; 12(2).
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.